Support vector machines: Development of QSAR models for predicting anti-HIV-1 activity of TIBO derivatives

European Journal of Medicinal Chemistry
2010.0

Abstract

The tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepinone (TIBO) derivatives, as non-nucleoside reverse transcriptase inhibitors, acquire a significant place in the treatment of the infections by the HIV. In the present paper, the support vector machines (SVM) are used to develop quantitative relationships between the anti-HIV activity and four molecular descriptors of 82 TIBO derivatives. The results obtained by SVM give good statistical results compared to those given by multiple linear regressions and artificial neural networks. The contribution of each descriptor to structure-activity relationships was evaluated. It indicates the importance of the hydrophobic parameter. The proposed method can be successfully used to predict the anti-HIV of TIBO derivatives with only four molecular descriptors which can be calculated directly from molecular structure alone.

Knowledge Graph

Similar Paper

Support vector machines: Development of QSAR models for predicting anti-HIV-1 activity of TIBO derivatives
European Journal of Medicinal Chemistry 2010.0
MIA–QSAR coupled to principal component analysis-adaptive neuro-fuzzy inference systems (PCA–ANFIS) for the modeling of the anti-HIV reverse transcriptase activities of TIBO derivatives
European Journal of Medicinal Chemistry 2010.0
QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine
European Journal of Medicinal Chemistry 2009.0
Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. 2
Journal of Medicinal Chemistry 1991.0
QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM)
Bioorganic & Medicinal Chemistry Letters 2017.0
Synthesis of the pyrimidine analog of 4,5,6,7-tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)one (TIBO) potential for HIV-1 inhibition
Bioorganic & Medicinal Chemistry Letters 1991.0
Exploring QSAR of antiamoebic agents of isolated natural products by MLR, ANN, and RTO
Medicinal Chemistry Research 2012.0
Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives
Journal of Medicinal Chemistry 1991.0
QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors
European Journal of Medicinal Chemistry 2010.0
Docking and 3-D QSAR Studies on Indolyl Aryl Sulfones. Binding Mode Exploration at the HIV-1 Reverse Transcriptase Non-Nucleoside Binding Site and Design of Highly Active N-(2-Hydroxyethyl)carboxamide and N-(2-Hydroxyethyl)carbohydrazide Derivatives
Journal of Medicinal Chemistry 2005.0